Greer Laboratories Overview
- Year Founded
-
1904
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
Greer Laboratories General Information
Description
Provider of allergenic extracts in the United States for the diagnosis and treatment of allergies in both humans and animals. The company offers human and veterinary allergy products, including pollen, fungi and smuts, antigens, standardized and custom mixture, as well as epithelia, insect and miscellaneous inhalant extracts; as well as sterile diluting fluids, sterile empty vials and caps, safety syringes, syringes and syringe trays, vial trays and racks and skin testing devices.
Contact Information
Website
www.greerlabs.comCorporate Office
- 639 Nuway Circle Northeast
- PO Box 800
- Lenoir, NC 28645
- United States
Corporate Office
- 639 Nuway Circle Northeast
- PO Box 800
- Lenoir, NC 28645
- United States
Greer Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Greer Laboratories Patents
Greer Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140276197-A1 | Apparatus and method for determining treatment endpoints for allergen testing | Inactive | 15-Mar-2013 | ||
| US-20130231583-A1 | Methods and compositions for injection delivery | Inactive | 02-Mar-2012 | ||
| WO-2013130821-A1 | Methods and compositions for injection delivery | Inactive | 02-Mar-2012 | ||
| US-20050175638-A1 | Desensitization immunotherapy; increasing concentration exposure regimen | Active | 06-Feb-2004 | ||
| US-8491909-B2 | Desensitization immunotherapy; increasing concentration exposure regimen | Inactive | 06-Feb-2004 | A61K39/36 |
Greer Laboratories Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Greer Laboratories Investments (1)
Greer Laboratories’s most recent deal was a Buyout/LBO with Antigen Laboratories. The deal was made on 15-Apr-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Antigen Laboratories | 15-Apr-2013 | Buyout/LBO | Laboratory Services (Healthcare) |
Greer Laboratories FAQs
-
When was Greer Laboratories founded?
Greer Laboratories was founded in 1904.
-
Where is Greer Laboratories headquartered?
Greer Laboratories is headquartered in Lenoir, NC.
-
What industry is Greer Laboratories in?
Greer Laboratories’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Greer Laboratories a private or public company?
Greer Laboratories is a Private company.
-
What is Greer Laboratories’s current revenue?
The current revenue for Greer Laboratories is .
-
Who are Greer Laboratories’s investors?
Raymond James Capital has invested in Greer Laboratories.
-
When was Greer Laboratories acquired?
Greer Laboratories was acquired on 08-Sep-2015.
-
Who acquired Greer Laboratories?
Greer Laboratories was acquired by Stallergenes Greer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process